Conmed (CNMD) Gross Profit (2010 - 2026)

Conmed has reported Gross Profit for 17 years, with the latest figure at $183.4 million in Q1 2026.

• For the quarter ending Q1 2026, Gross Profit rose 3.2% year-over-year to $183.4 million; the trailing twelve-month figure through Mar 2026 stood at $756.2 million (up 2.35% YoY), and the FY2025 full-year result was $750.5 million, up 2.38% from the prior year.
• Gross Profit for Q1 2026 stood at $183.4 million, down from $218.3 million in the prior quarter.
• The five-year high for Gross Profit was $218.3 million in Q4 2025, with the low at $131.9 million in Q4 2022.
• Historically, Gross Profit has averaged $171.4 million across 5 years, with a median of $172.0 million in 2024.
• Annual changes were most pronounced in 2022 — Gross Profit fell 15.39% — and 2023, when it surged 38.16%.
• Conmed's Gross Profit stood at $131.9 million in 2022, then surged by 38.16% to $182.2 million in 2023, then gained by 8.88% to $198.3 million in 2024, then increased by 10.05% to $218.3 million in 2025, then decreased by 15.96% to $183.4 million in 2026.
• The last three Gross Profit figures came in at $183.4 million (Q1 2026), $218.3 million (Q4 2025), and $166.1 million (Q3 2025), per Business Quant data.